Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 29,403 | -45,532 | -21,824 | 1,262 | -84,134 |
| Depreciation Amortization | 9,326 | 6,942 | 4,590 | 2,412 | 10,247 |
| Accounts receivable | -1,603 | 3,428 | 3,888 | 7,909 | -6,671 |
| Accounts payable and accrued liabilities | -5,072 | -2,955 | -1,039 | -4,129 | 1,713 |
| Other Working Capital | -3,286 | 94,098 | 95,542 | 101,657 | -3,004 |
| Other Operating Activity | -9,265 | -22,215 | -29,583 | -33,748 | 3,537 |
| Operating Cash Flow | $19,503 | $33,766 | $51,574 | $75,363 | $-78,312 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -218,283 | -119,855 | -56,750 | -54,210 | 64,883 |
| PPE Investments | -1,039 | -972 | -436 | -117 | -2,836 |
| Investing Cash Flow | $-219,322 | $-120,827 | $-57,186 | $-54,327 | $62,047 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -16,000 | -16,000 | -16,000 | -16,000 | N/A |
| Common Stock Issued | 233,839 | 107,962 | 827 | 199 | 8,548 |
| Other Financing Activity | 34,000 | 34,000 | 34,000 | 34,000 | 18,000 |
| Financing Cash Flow | $251,839 | $125,962 | $18,827 | $18,199 | $26,548 |
| Beginning Cash Position | 33,927 | 33,627 | 33,627 | 33,627 | 23,644 |
| End Cash Position | 85,947 | 72,528 | 46,842 | 72,862 | 33,927 |
| Net Cash Flow | $52,020 | $38,901 | $13,215 | $39,235 | $10,283 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19,503 | 33,766 | 51,574 | 75,363 | -78,312 |
| Capital Expenditure | -1,039 | -972 | -436 | -117 | -2,836 |
| Free Cash Flow | 18,464 | 32,794 | 51,138 | 75,246 | -81,148 |